I checked to confirm if we are likely to do our manufacturing at Peter Mac and it certainly appears that way.
https://www.petermac.org/news/milestone-australia-s-first-t-cell-therapy-manufacturing-license-awarded August 29, 2019 Peter MacCallum Cancer Centre welcomes the issuing of the first license to manufacture commercial T-Cell treatments, including breakthrough CAR T-Cell therapies, within Australia. The Therapeutic Goods Administration has awarded a T-Cells GMP manufacturing licence to Cell Therapies Pty Ltd, a company which is situated at Peter Mac.
I don't think we can underestimate the partnership we have Peter Mac and the ongoing support and fantastic position it puts Prescient. The following is Peter Mac's specialty division "Cell Therapies"
What's your take on the role that Peter Mac is likely to play in our monetization of Cell Pryme? I would imagine that we would need some sort contractural agreement of sort with Peter Mac. I can't imagine Peter Mac not wanting to use our cell manufacturing technology given its superirity, do you?
PS: I reckon @Un1qu3Nam3 deserves the Freddo Frog for Cell Pryme - A being the "Application" part of the equation. And, I reckon Steve enjoyed dangling that one out there for us as a bit of a guessing game.
PTX Price at posting:
19.0¢ Sentiment: Buy Disclosure: Held
